News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syros Pharma Reports Third Quarter 2016 Financial Results And Provides Business Update



11/14/2016 11:46:20 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals (NASDAQ:SYRS) today reported financial results for the quarter ended September 30, 2016 and provided an update on recent accomplishments and upcoming events.

“With the dosing of the first patient in our first clinical study, a Phase 2 trial of SY-1425 in genomically defined AML and MDS populations, we rapidly advanced the broad promise of our gene control platform into the clinic in less than four years since Syros’ inception,” said Nancy Simonian, M.D., Chief Executive Officer of Syros.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES